论文部分内容阅读
本文旨在确定一组大系列病例的初步结果,弄清抗-HCV阳性肝细胞癌是否存在特殊的临床特征,并探讨HCV在肝细胞癌(HCC)的发生和发展中的地位。病人分为HCC (97例)和慢性肝病(CLD,223例),每组又分为HBsAg阳性、酒精及隐源性三个亚组。HCC组均有肝硬化。血清学检测包括:抗-HCV、HBV(HBsAg、抗-HBs、抗-HBc)及AFP。临床参数包括确诊时年龄、男女比例、确诊HCC前患CLD的时间、输血和手术史,癌直径和癌结节数及存活月数等。
This article aims to determine the initial results of a large series of cases to determine whether there are specific clinical features of anti-HCV positive hepatocellular carcinoma and to investigate the role of HCV in the development and progression of hepatocellular carcinoma (HCC). Patients were divided into HCC (97 cases) and chronic liver disease (CLD, 223 cases), each group is divided into HBsAg-positive, alcohol and cryptogenic three subgroups. HCC group had cirrhosis. Serological tests include: anti-HCV, HBV (HBsAg, anti-HBs, anti-HBc) and AFP. Clinical parameters include age at diagnosis, male-female ratio, time to diagnosis of pre-HCC CLD, history of blood transfusion and surgery, diameter of cancer, number of nodules and number of surviving months.